BMS-387032 Drug Record

  • BMS-387032 chembl:CHEMBL296468 Antineoplastic

    Alternate Names:

    SNS 032
    SNS-032
    BMS-387032

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    Pharmaceutical Developer Sunesis
    Source Reported Drug Name(s) SNS-032
    Drug Class Pan-CDK Inhibitor
    (2 More Sources)

    Publications:

  • BMS-387032   CDK9

    Interaction Score: 1.08

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Reported Cancer Type Melanoma
    Trial Name SNS-032
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    DTC TdgClinicalTrial ChemblInteractions CancerCommons TTD

  • BMS-387032   CDK7

    Interaction Score: 1.03

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Reported Cancer Type Melanoma
    Direct Interaction yes
    Mechanism of Interaction Cyclin-dependent kinase 7 inhibitor

    PMIDs:
    None found


    Sources:
    DTC TdgClinicalTrial ChemblInteractions CancerCommons TTD

  • BMS-387032   DYRK1B

    Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   CDK2

    Interaction Score: 0.31

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Cyclin-dependent kinase 2 inhibitor
    Direct Interaction yes
    Reported Cancer Type Melanoma

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions CancerCommons TTD

  • BMS-387032   MELK

    Interaction Score: 0.28

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   CDK8

    Interaction Score: 0.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   DYRK1A

    Interaction Score: 0.23

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   GSK3A

    Interaction Score: 0.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   TAOK1

    Interaction Score: 0.15

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   PRKD3

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   CDK5

    Interaction Score: 0.11

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   GSK3B

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BMS-387032   CLK4

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CancerCommons: SNS-032

    • Version: 25-July-2013

    Alternate Names:
    N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide PubChem Drug Name
    3025986 PubChem Drug ID
    SNS-032 Drug Trade Name

    Drug Info:
    Drug Class Pan-CDK Inhibitor
    Source Reported Drug Name(s) SNS-032
    Pharmaceutical Developer Sunesis

    Publications:

  • TdgClinicalTrial: SNS-032

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • DTC: BMS-387032

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL296468 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: SNS-032

    • Version: 2020.06.01

    Alternate Names:
    D0S5RC TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL296468

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL296468

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: